Chronic GVHD risk score: A Center for International Blood and Marrow Transplant Research analysis

Blood

Volumn 117, Issue 24, 2011, Pages 6714-6720

  Arora, Mukta ^a   Klein, John P ^b   Weisdorf, Daniel J ^a   Hassebroek, Anna ^c   Flowers, Mary E D ^d   Cutler, Corey S ^e   Urbano Ispizua, Alvaro ^f   Antin, Joseph H ^e   Bolwell, Brian J ^g   Boyiadzis, Michael ^h   Cahn, Jean Yves ⁱ   Cairo, Mitchell S ^j   Isola, Luis ^k   Jacobsohn, David A ^l   Jagasia, Madan ^m   Klumpp, Thomas R ⁿ   Lee, Stephanie J ^d   Petersdorf, Effie W ^d   Santarone, Stella ^o   Gale, Robert Peter ^p   Schouten, Harry C ^q   Spellman, Stephen ^d   Wingard, John R ^r   Horowitz, Mary M ^b   Pavletic, Steven Z ^s   more..

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f HOSPITAL CLÍNIC   (Spain)

^g TAUSSIG CANCER INSTITUTE   (United States)

^h UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ TEMPLE UNIVERSITY   (United States)

^o Ospedale Civile di Pescara   (Italy)

^p CELGENE CORPORATION   (United States)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF FLORIDA   (United States)

^s NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MORTALITY; OVERALL SURVIVAL; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; SURVIVAL RATE; THROMBOCYTE COUNT;

EID: 79959193801     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-323824     Document Type: Article

References (20)

1. Fraser CJ, Bhatia S, Ness K, et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood. 2006;108(8):2867-2873.
2. Socié G, Stone JV, Wingard JR, et al. Longterm survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341(1):14-21.
3. Akpek G, Lee SJ, Flowers ME, et al. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood. 2003;102(3):802-809. (Pubitemid 36917767)
4. Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood. 2001; 97(5):1219-1226. (Pubitemid 32183742)
5. Arora M, Burns LJ, Davies SM, et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant. 2003;9(1):38-45. (Pubitemid 41123052)
6. Arora M, Nagaraj S, Wagner JE, et al. Chronic graft-versus-host disease (cGVHD) after unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB). Biol Blood Marrow Transplant. 2007;13(10):1145-1152. (Pubitemid 47413011)
7. Lee SJ, Klein JP, Barrett AJ, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood. 2002;100(2):406-414. (Pubitemid 34761100)
8. Martin PJ, Storer BE, Carpenter PA, et al. Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17(1):124-132.
9. Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood. 1988;72(2):546-554.
10. Wingard JR, Piantadosi S, Vogelsang GB, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood. 1989;74(4):1428-1435. (Pubitemid 19227458)
11. Stewart BL, Storer B, Storek J, et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood. 2004;104(12):3501-3506. (Pubitemid 39564419)
12. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97(4): 855-864. (Pubitemid 27321388)
13. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217. (Pubitemid 10036817)
14. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-956. (Pubitemid 41754712)
15. Eapen M, Logan BR, Confer DL, et al. Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biol Blood Marrow Transplant. 2007;13(12):1461-1468. (Pubitemid 350091382)
16. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706. (Pubitemid 29126745)
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53(282):457-481.
18. Cox D. Regression models and life tables. J R Stat Soc B. 1972;34(2):187-220.
19. Vigorito AC, Campregher PV, Storer BE, et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood. 2009;114(3):702-708.
20. Weisdorf D, Spellman S, Haagenson M, et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant. 2008;14(7):748-758. (Pubitemid 351773151)